ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,846Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 82

$1.32M Total Retail Price of All Prescriptions

Rank: 2 out of 82

666 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 666 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 666 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,730 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$103 was the average price of a prescription from this provider, compared to $108 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
PREDNISONE 1,132 751 1 2
HYDROCODONE-ACETAMINOPHEN 760 321 S3 2 4
GABAPENTIN 651 334 3 7
METHOTREXATE 581 442 4 1
ZOLPIDEM TARTRATE 486 213 5 19
MELOXICAM 478 311 6 8
ALLOPURINOL 290 209 7 12
OXYCODONE-ACETAMINOPHEN 288 124 S2 8 31
LYRICA 256 82 9 21
CYMBALTA 249 122 10 17
LEFLUNOMIDE 249 194 10 6
CARISOPRODOL 227 67 R 12 25
PANTOPRAZOLE SODIUM 210 145 13 58
TRAMADOL HCL 210 114 13 5
TRAZODONE HCL 209 50 15 28
FUROSEMIDE 188 96 16 24
SIMVASTATIN 185 93 17 13
OMEPRAZOLE 169 93 18 9
LEVOTHYROXINE SODIUM 159 76 19 11
FENTANYL 149 39 S2 20 44
CYCLOBENZAPRINE HCL 146 24 R 21 14
HYDROXYCHLOROQUINE SULFATE 146 88 21 3
OXYCODONE HCL-ACETAMINOPHEN 129 52 S2 23 35
SULFASALAZINE 128 67 24 42
CITALOPRAM HBR 124 92 25 39
CELEBREX 123 76 26 20
LISINOPRIL 121 66 27 16
MORPHINE SULFATE ER 118 37 S2 28 38
ROPINIROLE HCL 118 41 28 56
ULORIC 116 82 30 76
NEXIUM 114 56 31 43
AZATHIOPRINE 109 80 32 23
HUMIRA 108 59 33 22
AMLODIPINE BESYLATE 101 51 34 15
POTASSIUM CHLORIDE 99 55 35 27
ENBREL 94 55 36 18
KLOR-CON 10 88 51 37 86
METOPROLOL TARTRATE 81 47 38 37
SERTRALINE HCL 81 37 38 60
IMIPRAMINE HCL 80 26 R 40 124
ESCITALOPRAM OXALATE 79 52 41 79
OXYCONTIN 74 21 S2 42 55
MORPHINE SULFATE 73 21 S2 43 130
METHADONE HCL 72 12 S2 44 66
OXYCODONE HCL 67 16 S2 45 54
MYCOPHENOLATE MOFETIL 66 30 46 88
FLUOXETINE HCL 64 30 47 81
CRESTOR 61 25 48 59
METFORMIN HCL 60 50 49 34
CLONAZEPAM 58 0 50 143
ZETIA 52 25 51 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 26, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.